Page 39 | March 2016
Page 104 | June 2018
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key f
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
The Japanese biotechnology industry had total revenues of USD 37.6bn in 2014, representing a compound annual growth rate (CAGR) of 3.6% between 2010 and 2014.
The environment and industrial processing segment was the industry's most lucrative in 2014, with total revenues of USD 12.7bn, equivalent to 33.8% of the industry's overall value.
The performance of the industry is forecast to decelerate, with an anticipated CAGR of 2.9% for the five-year period 2014-2019, which is expected to drive the industry to a value of USD 43.4bn by the end of 2019.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Japan economy
Reasons To Buy
What was the size of the Japan biotechnology market by value in 2014?
What will be the size of the Japan biotechnology market in 2019?
What factors are affecting the strength of competition in the Japan biotechnology market?
How has the market performed over the last five years?
Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceutical Company Limited
|History||Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.|